NCT01505504View on ClinicalTrials.gov

Mirtazapine in Alzheimer-associated Weight Loss

CompletedOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

November 30, 2011

Study Completion Date

December 31, 2011

Conditions
Alzheimer's DiseaseWeight LossMixed DementiaDementia
Interventions
DRUG

mirtazapine

30 mg at bedtime

Trial Locations (1)

1020

CHU Brugmann, Brussels

All Listed Sponsors
lead

Brugmann University Hospital

OTHER

NCT01505504 - Mirtazapine in Alzheimer-associated Weight Loss | Biotech Hunter | Biotech Hunter